Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
How did MoneyWorks4me help subscribers to buy Divis Lab at Rs. 629/ share in 2017?
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Paushak Ltd Stock Analysis

Small Cap
Evaluated by 643 users | BSE: 532742 | NSE: |
Chemicals

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Capital Employed 10.85%21.53%20.26%25.18%19.56%10.22%20.93%21.1%15.99%14.4%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 33.650.856.36977.966.7103140138141132
Y-o-Y Gr. Rt.-51.3%10.9%22.5%12.9%-14.4%55.2%34.9%-1.2%2.2%-
Adjusted EPS (Rs.) 10.324.1826.5340.4838.5324.1263.9999.4104.81116.44102.49
Y-o-Y Gr. Rt.-134.8%9.7%52.6%-4.8%-37.4%165.3%55.3%5.4%11.1%-
Book Value per Share (Rs.) 97.59118.39142.41178.96214.07258.86352.75576.12737.3881.43890.93
Adjusted Net Profit 3.37.88.51312.47.720.530.632.335.932
Net Op. Cash Flow (Rs. Cr.) 1.42.59.48.713.512.410.523.545.429.8-
Debt to Cash Flow from Ops 2.010.4700.030.0400.05000-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Paushak Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales 17.3%12.6%10.9%2.2%
Adjusted EPS 30.9%24.8%22.1%11.1%
Book Value per Share 27.732.735.719.6
Share Price 69.1% 74% 72.4% 180.5%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity (%) 11.0322.3920.3425.1919.6110.220.9221.0815.9614.3911.57
Operating Profit Margin (%) 14.6923.0522.8125.3421.5318.628.3828.8231.0635.8434.16
Net Profit Margin (%) 9.8415.2615.118.8215.8711.6119.8421.9623.4225.4523.99
Debt to Equity 0.090.03000.0100.01000-
Working Capital Days 196175196159132142137139135134-
Cash Conversion Cycle 87819383839577807558-
Loading price chart...
Entity Percentage Holding
Promoters 66.97%
Institutions 0.04%
Non-Institutions 33.00%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Paushak Ltd's earnings have grown by 24.8%, whereas share price has appreciated 74% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Paushak Ltd share price has appreciated 69.1% annually (CAGR) over the past ten years.

Data is not available for this company.

Paushak, an Alembic Group company, was established in 1972, 40 Kms outside Vadodara (Gujarat) and about 400 Kms north of Mumbai. Over the years the company has established a multi product capability in Phosgene & its derivatives manufacturing.

In last more than 25 years the experience of the company has given it an Indigenous process development capability. The company has also handled custom synthesis and contract based research.

The company offers a high degree of supply

Paushak, an Alembic Group company, was established in 1972, 40 Kms outside Vadodara (Gujarat) and about 400 Kms north of Mumbai. Over the years the company has established a multi product capability in Phosgene & its derivatives manufacturing.

In last more than 25 years the experience of the company has given it an Indigenous process development capability. The company has also handled custom synthesis and contract based research.

The company offers a high degree of supply reliability for large scale products and speciality chemicals. Its production complex consists of multiple products plants that can be fine turned to run under optimal conditions for a given product.

It has been manufacturing Phosgene for mare than three decades from the basic raw materials. Paushak is producing more than 150 tons of Phosgene per month. Paushak has production capacity of 150 tons per month of phosgene with a turnover of $ 3.5 Million per annum with a workforce of 200 plus.

The company has an in-house process development and R & D laboratory. They also have corporate support in production, R&D, QA, etc.

Phosgene is a versatile molecule and its derivatives have applications in diverse fields like pharmaceuticals, agrochemicals , polyurethanes, perfumeries, dyes, etc.

Product range of the company includes:

  • Isocyanates
  • Chloroformates
  • Carbamoyl Chlorides
  • Urea & Other

Achievements/ recognition:

  • Certificate of merit for the years 1990-91 & 1991-1992 by Chemexcil (Government of India)
  • Recognized for export performance by government of Gujarat in the year 1991-1992
  • Recognized for its contribution towards environment in the year 1997 by Forest Department (State government).
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback